Delivery Order SPE2DB20D2104-SPE2DB23FS84P
- Not listed
- This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 mL) to the Defense Logistics Agency (DLA). The $5,296.28 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of November 8, 2024 and is not designated as a set-aside requirement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml capacity. The contract, valued at $3,531.84, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on November 6, 2024. The contract has a completion date of November 7, 2024 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pen 3 mL to the Defense Logistics Agency (DLA). The $57,987.46 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 3, 2023, with an ultimate completion date of April 4, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 mL) to the Defense Logistics Agency (DLA). The $32,903.29 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of June 5, 2024 and was not designated with a set-aside requirement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pen, 3 ml, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,498.14 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 24, 2024, with a completion date of September 25, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $12,869.72 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 28, 2025 and was not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp covers the delivery of Ozempic 0.25-0.5 mg/dose pens in 3 mL sizes. The fixed-price, firm-fixed delivery order has a ceiling value of $4,272.24 and an ultimate completion date of November 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a range of pharmaceutical products and medical...
- This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL capacity to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $2,168.13 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 11, 2024, with a completion date of December 12, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $8,959.79 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of July 31, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml volume. The $1,433.40 fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 21, 2023. The contract is not designated as a set-aside and represents open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS84PDelivery Order
This federal contract award is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 mL capacity to the Defense Logistics Agency (DLA). The $1,871.54 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 30, 2023. The contract has an ultimate completion date of March 31, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 3/30/23 |